These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4272998)

  • 21. [Clinical study of alclofenac in rheumatology. Cooperative study].
    Colinet E; Famaey JP
    J Belge Rhumatol Med Phys; 1971; 26(6):267-80. PubMed ID: 4948859
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrometric demonstration of hypersensitivity to antirheumatic drugs].
    Vlcek F
    Arch Klin Exp Dermatol; 1970; 237(1):207-9. PubMed ID: 4244588
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects and side effects of 3-chlor-4-allyloxy-phenylacetic acid (Mervan) in therapeutic study of rheumatic diseases].
    Klemm C; Fricke R; Schattenkirchner M; Treiber W; Mathies H
    Z Rheumaforsch; 1971; 30(1):17-25. PubMed ID: 5315910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Gougerot's trisymptom complex induced by anti-inflammatory agents. Role of diclofenac?].
    Bonafé JL; Mazières B; Bouteiller G
    Ann Dermatol Venereol; 1982; 109(3):283-4. PubMed ID: 7114742
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of some antirheumatic agents on the gastric mucous membrane].
    Vasilenko VKh; Tsodikov GV; Minushkin ON
    Klin Med (Mosk); 1971 Aug; 49(8):3-10. PubMed ID: 4331391
    [No Abstract]   [Full Text] [Related]  

  • 26. Withdrawal of alclofenac (Prinalgin).
    Mann RD
    Br Med J; 1979 Jul; 2(6182):133. PubMed ID: 37982
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.
    Anylward M; Davies DB
    Br J Clin Pract; 1972 Nov; 26(11):517-23. PubMed ID: 4563533
    [No Abstract]   [Full Text] [Related]  

  • 28. Gas chromatographic determination of 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and its metabolites.
    Roncucci R; Simon MJ; Lambelin G
    J Chromatogr; 1971 Oct; 62(1):135-7. PubMed ID: 5130009
    [No Abstract]   [Full Text] [Related]  

  • 29. Withdrawal of alclofenac (Prinalgin).
    Mann RD
    Lancet; 1979 Jul; 2(8132):52. PubMed ID: 87941
    [No Abstract]   [Full Text] [Related]  

  • 30. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects.
    Aylward M
    Br J Clin Pract; 1973 Jul; 27(7):255-60. PubMed ID: 4580332
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of 3-(4-chlorphenyl-) 1-phenyl-1H-pyrazole-4-acetic acid (lonazolac-Ca), diclofenac-Na and indomethacin on the gastrointestinal blood loss].
    Uthgenannt H; Arent H
    Wien Klin Wochenschr; 1982 Jun; 94(13):345-9. PubMed ID: 6982566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis.
    Van Hoek J
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):551-5. PubMed ID: 4989683
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
    Almeyda J; Baker H
    Br J Dermatol; 1970 Dec; 83(6):707-11. PubMed ID: 4250591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of the test on efficacy of alclofenac in chronic rheumatoid arthritis].
    Ryumachi; 1980 Sep; 20(4):305-21. PubMed ID: 6108616
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-rheumatic and analgesic drug usage and acute gastro-intestinal bleeding in elderly patients.
    Alexander AM; Veitch GB; Wood JB
    J Clin Hosp Pharm; 1985 Mar; 10(1):89-93. PubMed ID: 3873477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Flufenamic acid: therapeutic activity and secondary effects].
    Schiavetti L
    Clin Ter; 1972 Feb; 60(4):359-65. PubMed ID: 4260117
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of alclofenac and phenylbutazone effects in short-term therapy of chronic arthritis (double-blind test)].
    Pavelka K; Vojtísek O; Brémová A; Kanková D; Hándlová D
    Fysiatr Revmatol Vestn; 1973 Aug; 51(4):212-9. PubMed ID: 4578290
    [No Abstract]   [Full Text] [Related]  

  • 38. Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Oct; 14(4):241-59. PubMed ID: 21068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of alclofenac treatment regimes in man.
    Benedetti MS; Strolin P; Roncucci R; Simon MJ; Lambelin G; Nagant de Deuxchaisnes C
    Eur J Clin Pharmacol; 1973 Dec; 6(4):261-7. PubMed ID: 4204721
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse reactions of antirheumatic drugs.
    Bach GL
    Int J Clin Pharmacol; 1973 Apr; 7(2):198-205. PubMed ID: 4199904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.